Margolis, David M.

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

Hou, Y. J., Okuda, K., Edwards, C. E., Martinez, D. R., Asakura, T., Dinnon, K. H., Kato, T., Lee, R. E., Yount, B. L., Mascenik, T. M., et al. (2020) · Cell

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 1,488

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

Hou, Y. J., Chiba, S., Halfmann, P., Ehre, C., Kuroda, M., Dinnon, K. H., Leist, S. R., Schäfer, A., Nakajima, N., Takahashi, K., et al. (2020) · Science

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 900

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

Premkumar, L., Segovia-Chumbez, B., Jadi, R., Martinez, D. R., Raut, R., Markmann, A. J., Cornaby, C., Bartelt, L., Weiss, S., Park, Y., et al. (2020) · Science Immunology

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing

Cited by 868

The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation

Abrahams, M.-R., Joseph, S. B., Garrett, N., Tyers, L., Moeser, M., Archin, N., Council, O. D., Matten, D., Zhou, S., Doolabh, D., et al. (2019) · Science Translational Medicine

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 196

Lack of Pharmacokinetic Interaction between Rilpivirine and Integrase Inhibitors Dolutegravir and GSK1265744

Ford, S. L., Gould, E., Chen, S., Margolis, D., Spreen, W., Crauwels, H., & Piscitelli, S. (2013) · Antimicrobial Agents and Chemotherapy

HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions

Cited by 83

Selective HDAC Inhibition for the Disruption of Latent HIV-1 Infection

Barton, K. M., Archin, N. M., Keedy, K. S., Espeseth, A. S., Zhang, Y.-L., Gale, J., Wagner, F. F., Holson, E. B., & Margolis, D. M. (2014) · PLoS ONE

HIV Research and TreatmentHistone Deacetylase Inhibitors Research

Cited by 76

Analysis of the effect of HDAC inhibitors on the formation of the HIV reservoir

Ling, L., Kim, M., Soper, A., Kovarova, M., Spagnuolo, R. A., Begum, N., Kirchherr, J., Archin, N., Battaglia, D., Cleveland, D., et al. (2024) · mBio

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 14

Single-cell characterization of the gastrointestinal HIV reservoir reveals heterogeneous cellular phenotypes

Peterson, J. J., Chandel, S., James, K., Bennett, E. S., Wu, V., White, C. H., Allard, B., Clohosey, M., Whitaker, T., Baker, C., et al. (2026) · Journal of Clinical Investigation

HIV Research and TreatmentVirus-based gene therapy research

Cited by 7